These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21821124)

  • 1. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
    Ginsberg SD; Alldred MJ; Che S
    Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.
    Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
    Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.
    Alldred MJ; Duff KE; Ginsberg SD
    Neurobiol Dis; 2012 Feb; 45(2):751-62. PubMed ID: 22079237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
    Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
    Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
    Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
    Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
    Alldred MJ; Pidikiti H; Ibrahim KW; Lee SH; Heguy A; Hoffman GE; Mufson EJ; Stutzmann GE; Ginsberg SD
    J Alzheimers Dis; 2024; 100(s1):S341-S362. PubMed ID: 39031371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons.
    Ginsberg SD; Che S
    J Comp Neurol; 2005 Jun; 487(1):107-18. PubMed ID: 15861457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.
    He B; Perez SE; Lee SH; Ginsberg SD; Malek-Ahmadi M; Mufson EJ
    J Comp Neurol; 2020 Nov; 528(16):2748-2766. PubMed ID: 32323319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
    Hollnagel JO; Elzoheiry S; Gorgas K; Kins S; Beretta CA; Kirsch J; Kuhse J; Kann O; Kiss E
    PLoS One; 2019; 14(1):e0209228. PubMed ID: 30645585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.
    Neuman KM; Molina-Campos E; Musial TF; Price AL; Oh KJ; Wolke ML; Buss EW; Scheff SW; Mufson EJ; Nicholson DA
    Brain Struct Funct; 2015 Nov; 220(6):3143-65. PubMed ID: 25031178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-98 reduces amyloid β-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice.
    Chen FZ; Zhao Y; Chen HZ
    Int J Mol Med; 2019 Jan; 43(1):91-102. PubMed ID: 30365070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.
    Adams SL; Benayoun L; Tilton K; Chavez OR; Himali JJ; Blusztajn JK; Seshadri S; Delalle I
    J Alzheimers Dis; 2017; 60(1):43-56. PubMed ID: 28777754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease.
    Perez-Cruz C; Nolte MW; van Gaalen MM; Rustay NR; Termont A; Tanghe A; Kirchhoff F; Ebert U
    J Neurosci; 2011 Mar; 31(10):3926-34. PubMed ID: 21389247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.
    Blalock EM; Buechel HM; Popovic J; Geddes JW; Landfield PW
    J Chem Neuroanat; 2011 Oct; 42(2):118-26. PubMed ID: 21756998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice.
    Schaeffer EL; Catanozi S; West MJ; Gattaz WF
    Ann Anat; 2017 Jan; 209():51-60. PubMed ID: 27777112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
    FASEB J; 2019 Sep; 33(9):9871-9884. PubMed ID: 31180719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    Ruiter M; Herstel LJ; Wierenga CJ
    J Alzheimers Dis; 2020; 78(3):951-964. PubMed ID: 33074225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.